DK4393545T3 - Hidtil ukendte anvendelser af piperidinyl-indolderivater - Google Patents

Hidtil ukendte anvendelser af piperidinyl-indolderivater

Info

Publication number
DK4393545T3
DK4393545T3 DK24170648.0T DK24170648T DK4393545T3 DK 4393545 T3 DK4393545 T3 DK 4393545T3 DK 24170648 T DK24170648 T DK 24170648T DK 4393545 T3 DK4393545 T3 DK 4393545T3
Authority
DK
Denmark
Prior art keywords
indole derivatives
piperidinyl
unknown uses
unknown
piperidinyl indole
Prior art date
Application number
DK24170648.0T
Other languages
English (en)
Inventor
Jörg Eder
Richard Alexander Harrison
Boerje Haraldsson
Anna Svenja Schubart
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK4393545T3 publication Critical patent/DK4393545T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK24170648.0T 2017-08-31 2018-08-30 Hidtil ukendte anvendelser af piperidinyl-indolderivater DK4393545T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17188870 2017-08-31
EP18769510.1A EP3675854B1 (en) 2017-08-31 2018-08-30 Piperidinyl-indole derivatives for use in the treatment of c3 glomerulopathy

Publications (1)

Publication Number Publication Date
DK4393545T3 true DK4393545T3 (da) 2026-01-12

Family

ID=59745840

Family Applications (2)

Application Number Title Priority Date Filing Date
DK18769510.1T DK3675854T3 (da) 2017-08-31 2018-08-30 Piperidinyl-indolderivativer til anvendelse ved behandling af c3-glomerulopati
DK24170648.0T DK4393545T3 (da) 2017-08-31 2018-08-30 Hidtil ukendte anvendelser af piperidinyl-indolderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK18769510.1T DK3675854T3 (da) 2017-08-31 2018-08-30 Piperidinyl-indolderivativer til anvendelse ved behandling af c3-glomerulopati

Country Status (22)

Country Link
US (3) US11723901B2 (da)
EP (3) EP4393545B1 (da)
JP (3) JP6754919B1 (da)
KR (3) KR102682887B1 (da)
CN (5) CN117398384A (da)
AU (1) AU2018326768B2 (da)
BR (1) BR112020003737A2 (da)
CA (1) CA3073346A1 (da)
CL (1) CL2020000483A1 (da)
DK (2) DK3675854T3 (da)
ES (2) ES3022885T3 (da)
FI (2) FI3675854T3 (da)
HR (2) HRP20250386T1 (da)
HU (1) HUE071118T2 (da)
IL (1) IL272888B2 (da)
LT (2) LT4393545T (da)
MX (3) MX2020002185A (da)
PL (2) PL4393545T3 (da)
PT (2) PT4393545T (da)
RS (2) RS66635B1 (da)
SI (2) SI4393545T1 (da)
WO (1) WO2019043609A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020003737A2 (pt) 2017-08-31 2020-09-01 Novartis Ag usos de derivados de piperidinil-indol
WO2021125313A1 (ja) * 2019-12-19 2021-06-24 大鵬薬品工業株式会社 縮合ピリミジン化合物を有効成分とする治療剤
KR20250048392A (ko) 2020-05-18 2025-04-08 노파르티스 아게 Lnp023의 결정질 형태
US20230286947A1 (en) * 2020-08-07 2023-09-14 Shanghai Meiyue Biotech Development Co. Ltd Complement factor b inhibitor, and pharmaceutical composition, preparation method and use thereof
US20230331710A1 (en) * 2020-08-07 2023-10-19 Shanghai Meiyue Biotech Development Co. Ltd Heterocyclic compound, preparation method and use thereof
CN119798256A (zh) * 2020-12-30 2025-04-11 江苏恒瑞医药股份有限公司 含氮桥杂环化合物、其制备方法及其在医药上的应用
JP7641388B2 (ja) * 2020-12-30 2025-03-06 エス－インフィニティ ファーマシューティカルズ カンパニー リミテッド 一連のピペリジン置換安息香酸系化合物及びその使用
JP2024517234A (ja) * 2021-05-07 2024-04-19 ノバルティス アーゲー 非典型溶血性尿毒症症候群の処置のためのイプタコパン
CA3229360A1 (en) * 2021-08-18 2023-02-23 Chen Zhang Benzo nitrogen-containing heteroaromatic ring derivative and use thereof in medicine
EP4423076A4 (en) * 2021-10-27 2026-01-07 Hansoh Bio Llc PIPERIDINYL INDOLE DERIVATIVES, THEIR PREPARATION PROCESSES AND MEDICAL USES
CR20240300A (es) * 2022-01-24 2024-08-23 Novartis Ag Derivados espirocíclicos de piperidinilo como inhibidores del factor b del complemento y usos de los mismos.
EP4471021A4 (en) * 2022-01-26 2025-04-30 Shanghai Meiyue Biotech Development Co., Ltd. Salt type and crystal form of complement factor b inhibitor, and preparation method therefor and application thereof
CN119343347A (zh) * 2022-06-10 2025-01-21 正大天晴药业集团股份有限公司 双环取代的芳香羧酸酯类化合物
WO2023246677A1 (zh) * 2022-06-20 2023-12-28 深圳信立泰药业股份有限公司 一种吲哚-苯基哌啶化合物及其制备方法与应用
US20250382287A1 (en) 2022-06-30 2025-12-18 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Pharmaceutically acceptable salt and crystal form of nitrogen-containing bridge heterocyclic derivative, and method for preparing same
CN117327070A (zh) * 2022-06-30 2024-01-02 江苏恒瑞医药股份有限公司 一种含氮桥杂环衍生物的晶型及其制备方法
JP2025530222A (ja) * 2022-09-10 2025-09-11 江▲蘇▼豪森▲薬▼▲業▼集▲団▼有限公司 ２－置換ピペリジン誘導体、その製造方法及び医薬的用途
EP4617266A1 (en) 2022-11-11 2025-09-17 Shanghai Yisheng Biopharmaceutical company Limited Piperidine-substituted benzoic acid compound, and pharmaceutical composition and use thereof
WO2024141011A1 (zh) * 2022-12-31 2024-07-04 深圳晶泰科技有限公司 补体因子b抑制剂及其药物组合物和应用
TWI896250B (zh) * 2023-07-26 2025-09-01 大陸商上海美悦生物科技發展有限公司 螺環烯基類或氮雜烯基類化合物及其藥物組合物、製備方法和用途
WO2026086939A1 (zh) * 2024-10-25 2026-04-30 上海美悦生物科技发展有限公司 杂环化合物在制备预防或治疗IgA肾病的药物中的用途
WO2026093943A1 (en) 2024-10-31 2026-05-07 Novartis Ag Chemical process for preparing phenylpiperidinyl indole derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192742B2 (en) * 2007-03-23 2012-06-05 NovelMed Therapeutics Method of inhibiting complement activation with human anti-factor C3 antibodies and use thereof
ES2712190T3 (es) 2012-06-28 2019-05-09 Novartis Ag Moduladores de la vía del complemento y sus usos
CN105229003B (zh) * 2013-03-14 2017-03-15 诺华股份有限公司 作为补体因子b抑制剂用于治疗眼科疾病的2‑(1h‑吲哚‑4‑基甲基)‑3h‑咪唑并[4,5‑b]吡啶‑6‑甲腈衍生物
JO3425B1 (ar) * 2013-07-15 2019-10-20 Novartis Ag مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
AU2016375183B2 (en) * 2015-12-23 2021-01-21 eleva GmbH Polypeptides for inhibiting complement activation
SG11201805695SA (en) * 2016-01-05 2018-07-30 Univ Leicester Methods for inhibiting fibrosis in a subject in need thereof
BR112020003737A2 (pt) 2017-08-31 2020-09-01 Novartis Ag usos de derivados de piperidinil-indol
KR20250048392A (ko) 2020-05-18 2025-04-08 노파르티스 아게 Lnp023의 결정질 형태
US11951101B2 (en) 2020-07-16 2024-04-09 Novartis Ag Methods of using factor B inhibitors

Also Published As

Publication number Publication date
US20220152011A1 (en) 2022-05-19
EP4647121A2 (en) 2025-11-12
FI3675854T3 (fi) 2025-04-07
PT3675854T (pt) 2025-04-04
EP3675854B1 (en) 2025-01-22
WO2019043609A1 (en) 2019-03-07
HRP20250386T1 (hr) 2025-05-23
JP6754919B1 (ja) 2020-09-16
JP2020529466A (ja) 2020-10-08
LT3675854T (lt) 2025-04-25
RU2020111788A3 (da) 2021-12-28
EP4393545A3 (en) 2024-09-25
US12285422B2 (en) 2025-04-29
KR102682887B1 (ko) 2024-07-08
RS67530B1 (sr) 2026-01-30
KR20200047540A (ko) 2020-05-07
CN111032042A (zh) 2020-04-17
EP4647121A3 (en) 2026-02-18
JP6929425B2 (ja) 2021-09-01
ES3022885T3 (en) 2025-05-29
EP4393545A2 (en) 2024-07-03
RS66635B1 (sr) 2025-04-30
DK3675854T3 (da) 2025-04-07
AU2018326768A1 (en) 2020-02-06
IL272888A (en) 2020-04-30
SI4393545T1 (sl) 2026-02-27
KR20240111007A (ko) 2024-07-16
US20200338059A1 (en) 2020-10-29
MX2023010750A (es) 2023-09-20
ES3058507T3 (en) 2026-03-11
MX2023010751A (es) 2023-09-20
BR112020003737A2 (pt) 2020-09-01
PL4393545T3 (pl) 2026-03-16
IL272888B1 (en) 2023-09-01
KR102497487B1 (ko) 2023-02-08
EP3675854A1 (en) 2020-07-08
CN117338782A (zh) 2024-01-05
CN117338781A (zh) 2024-01-05
FI4393545T3 (fi) 2026-01-14
CN117398384A (zh) 2024-01-16
CA3073346A1 (en) 2019-03-07
US20250195493A1 (en) 2025-06-19
PT4393545T (pt) 2025-12-23
CL2020000483A1 (es) 2020-09-04
HRP20251596T1 (hr) 2026-01-30
SI3675854T1 (sl) 2025-05-30
LT4393545T (lt) 2026-01-12
RU2020111788A (ru) 2021-09-30
IL272888B2 (en) 2024-01-01
AU2018326768B2 (en) 2021-07-29
EP4393545B1 (en) 2025-10-08
CN117338783A (zh) 2024-01-05
PL3675854T3 (pl) 2025-05-19
HUE071118T2 (hu) 2025-08-28
KR20230024432A (ko) 2023-02-20
JP2020193222A (ja) 2020-12-03
US11723901B2 (en) 2023-08-15
JP7297016B2 (ja) 2023-06-23
MX2020002185A (es) 2020-07-14
JP2021181471A (ja) 2021-11-25

Similar Documents

Publication Publication Date Title
EP3496717A4 (en) 4-substituted aminoisoquinoline derivatives
DK3515297T3 (da) Biosymmetrisk sammenligning af subepidermale fugtværdier
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
PL4393545T3 (pl) Nowe zastosowania pochodnych piperydynylo-indolowych
DK3642202T3 (da) Dihydro-pyrrolo-pyridin-derivater
DK3509581T3 (da) Formuleringer af (r)-2-amino-3-phenylpropylcarbamat
EP3436004C0 (en) SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRUS INHIBITORS
DK3204378T3 (da) N-pyridinylacetamidderivater som hæmmere af wnt-signaleringsbanen
LT3436437T (lt) Pakeistieji indolo dariniai kaip dengės viruso replikacijos inhibitoriai
IL265166B (en) Anti-influenza virus pyrimidine derivatives
PL3457851T3 (pl) Pochodne sobetiromu
DK3630724T3 (da) Substituerede indolinderivater som inhibitorer af virusreplikation af denguevirus
DK3448846T3 (da) Syntese af indazoler
PL3625224T3 (pl) Pochodne n-podstawionego indolu
DK3551625T3 (da) Heterocykliske inhibitorer af mct4
JOP20170120A1 (ar) مشتقات اندول حلقية ضخمة
IL272851A (en) Methods of using dipivefrin
EP3684772C0 (en) CYCLIC IMINOPYRIMIDINE DERIVATIVES AS KINASE INHIBITORS
LT3402792T (lt) Chinolin-2-ono dariniai
DK3448849T3 (da) Syntese af indazoler
DK3371168T3 (da) Indolin-2-on-derivater
DK3474822T3 (da) Formuleringer af brincidofovir
DK3418273T3 (da) Derivater af flavagliner
PL3898637T3 (pl) Pochodne rapamycyny